Welcome
Support Centre
23 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Bridging the transition from hospital to home: Effects of the VITAL Telehealth Program on recovery for CABG patients and their caregivers
ISRCTN ISRCTN77474147
ClinicalTrials.gov identifier
Public title Bridging the transition from hospital to home: Effects of the VITAL Telehealth Program on recovery for CABG patients and their caregivers
Scientific title
Acronym N/A
Serial number at source AØ6-B22-04A
Study hypothesis 1. CABG patients who participate in the VITAL program will have a significantly greater decrease in anxiety between entry into the program and at 2 weeks after program completion as compared to CABG patients who receive usual care.
2. Caregivers of CABG patients who participate in the VITAL program will have a significantly greater decrease in anxiety between entry into the program and at 2 weeks after program completion as compared to caregivers of CABG patients who receive usual care.
Lay summary Not provided at time of registration
Ethics approval McGill University, Montreal QC and Atlantic Health Sciences Corporation, Saint John NB
Study design Randomised controlled trial
Countries of recruitment Canada
Disease/condition/study domain Recovery from coronary artery bypass graft surgery
Participants - inclusion criteria 1. The patient is undergoing first-time CABG surgery
2. The patient is hospitalized and waiting for CABG surgery, or is admitted to hospital for surgery after being on the cardiac wait list
3. There is a caregiver available and present on admission and/or during the patient’s hospitalization
4. There is a telephone in the home
5. There is a grounded electrical outlet, or three-prong plug outlet, in the home
6. The patient and caregiver speak and understand English and are cognitively able to participate in the interviews
7. Both the patient and caregiver will be likely to be able to adhere with the VITAL program
8. The patient and caregiver both consent to participate
Participants - exclusion criteria 1. Patient is scheduled for valve replacement surgery
2. An attending physician believes it is necessary for a patient to have the VITAL program upon discharge.
Anticipated start date 03/01/2005
Anticipated end date 30/04/2007
Status of trial Completed
Patient information material
Target number of participants 174
Interventions Participants are randomly assigned to receive usual follow-up care or follow-up care with telehealth equipment. Patients and their caregivers in both groups receive all the usual cardiac teaching that is available during hospitalization. This consists of cardiac instruction from a multidisciplinary health care team on the day of admission to hospital, and on the second, third and fourth post-operative days. Patients are advised to follow-up with their family physician one week after discharge and then to return for a 6 week appointment with the cardiac surgeon.
Caregivers of patients who are assigned to receive follow-up with the telehealth equipment are also provided with two instructional sessions post-operatively and this then enables them to take the equipment home for one week. Having the telehealth equipment at home allows for daily audio-video visits between a patient’s home and the hospital. These daily sessions last approximately 30 minutes each.
Primary outcome measure(s) The 20-item State Anxiety Inventory (S-STAI) administered by telephone pre-operatively at baseline and at 5 days and 3 weeks after discharge
Secondary outcome measure(s) 1. Center for Epidemiologic Studies Depression Scale -10 (CESD-10) administered pre-operatively at baseline and at 5 days and 3 weeks after discharge
2. Health Care Utilization data collected at 5 days and 3 weeks after discharge
Sources of funding 1. Heart & Stroke Foundation of Canada Fellowship
2. McGill University
3. Groupe de recherche interuniversitaire
en soins infirmiers de Montréal (GRISIM) Fellowship
Trial website
Publications
Contact name Mrs  Lisa  Keeping
  Address 54 Clipper Passage
  City/town Saint John, New Brunswick
  Zip/Postcode E2K0A9
  Country Canada
Sponsor McGill University (Canada)
  Address 3506 University Street
School of Nursing
  City/town Montreal QC
  Zip/Postcode H3A2A7
  Country Canada
  Sponsor website: http://www.nursing.mcgill.ca/
Date applied 06/09/2005
Last edited 04/08/2011
Date ISRCTN assigned 13/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central